Valuation: Becton, Dickinson and Company

Market Cap 4.98TCr 4.38TCr 4.11TCr 3.76TCr 7.03TCr 4,77500Cr 7.08TCr 49TCr 19TCr 2,43400Cr 19TCr 18TCr 7,89300Cr P/E 2026 *
35.3x
P/E 2027 * 19.7x
Enterprise Value 6.57TCr 5.77TCr 5.42TCr 4.96TCr 9.27TCr 6,29700Cr 9.33TCr 65TCr 25TCr 3,21000Cr 25TCr 24TCr 10,40800Cr EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.23x
Free-Float
73.18%
Yield 2026 *
2.14%
Yield 2027 * 2.18%
1 day-0.54%
1 week+0.33%
Current month-3.01%
1 month-4.35%
3 months+26.77%
6 months+16.78%
Current year-5.99%
1 week 179.42
Extreme 179.42
184.37
1 month 175.2
Extreme 175.2
193.07
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
269.52
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
02/09/26 Tax

Chief Financial Officer

-190 0.0001%
26/08/26 Sell

Executive/Senior Manager

-165 0.0001%
20/08/26 Tax

Executive/Senior Manager

-1,049 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%+0.33%-2.18%-31.61% 4.98TCr
-0.12%+1.54%-23.51%+6.64% 18TCr
-1.76%-3.53%-5.93%+11.70% 12TCr
-0.57%-2.01%+3.21%+66.70% 6TCr
-0.22%+1.23%+7.80%+45.79% 4.8TCr
-1.92%+0.16%+28.27%+1.65% 3.38TCr
-1.32%+2.83% - - 3.02TCr
+1.08%+3.25%+49.04%-0.48% 2.61TCr
-0.39%+6.03%+9.83%-9.35% 2.3TCr
-2.33%-0.20%-8.89%+8.91% 2.1TCr
Average -0.82%+1.47%+6.40%+11.11% 5.87TCr
Weighted average by Cap. -0.74%+0.41%-3.90%+12.91%

Financials

2026 *2027 *
Net sales 1.93TCr 1.69TCr 1.59TCr 1.45TCr 2.71TCr 1,84500Cr 2.73TCr 19TCr 7.4TCr 94TCr 7.23TCr 7.07TCr 3,05000Cr 1.97TCr 1.73TCr 1.63TCr 1.49TCr 2.78TCr 1,89000Cr 2.8TCr 20TCr 7.58TCr 96TCr 7.41TCr 7.25TCr 3,12500Cr
Net income 143.66Cr 126.09Cr 118.53Cr 108.37Cr 202.5Cr 14TCr 204Cr 1.42TCr 551.93Cr 7.02TCr 539.5Cr 527.67Cr 23TCr 233.95Cr 205.34Cr 193.02Cr 176.47Cr 329.76Cr 22TCr 332.21Cr 2.32TCr 898.79Cr 11TCr 878.55Cr 859.3Cr 37TCr
Net Debt 1.59TCr 1.39TCr 1.31TCr 1.2TCr 2.24TCr 1,52200Cr 2.26TCr 16TCr 6.1TCr 78TCr 5.97TCr 5.83TCr 2,51500Cr 1.4TCr 1.22TCr 1.15TCr 1.05TCr 1.97TCr 1,33600Cr 1.98TCr 14TCr 5.36TCr 68TCr 5.24TCr 5.12TCr 2,20900Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
24/26/24 $182.32 -0.37% 4,64,662
22/26/22 $183.00 +1.27% 14,61,173
21/26/21 $180.70 -0.13% 14,61,542
18/26/18 $180.94 -0.24% 64,16,945
17/26/17 $181.38 -0.26% 18,39,784
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
183.00USD
Average target price
195.67USD
Spread / Average Target
+6.92%

Quarterly revenue - Rate of surprise